Cargando…

Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis – A Systematic Review of Population-Based Data

PURPOSE: Early studies showed that the risks of mRNA vaccine-associated myocarditis and pericarditis are low but with substantial variation across studies. Study characteristics, ethnicity, vaccine types, dose intervals, and SARS-CoV-2 infection prevalence may influence the rates of myocarditis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yen-Ching, Chang, Chia-Hsuin, Su, Wei-Ju, Yang, Chin-Hui, Wang, Jann-Tay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575036/ https://www.ncbi.nlm.nih.gov/pubmed/37841076 http://dx.doi.org/10.2147/RMHP.S422372

Ejemplares similares

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
por: Su, Wei-Ju, et al.
Publicado: (2023)

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
por: Le Vu, Stéphane, et al.
Publicado: (2022)

Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
por: Fujii, Masayoshi, et al.
Publicado: (2023)

COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Sustained Myocarditis following Messenger RNA Vaccination against Coronavirus Disease 2019: Relation to Neutralizing Antibody and Amelioration by Low-Dose Booster Vaccination
por: Miyazaki, Koji, et al.
Publicado: (2023)

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021)

PRAC updates risk of myocarditis and pericarditis with mRNA vaccines
Publicado: (2021)

Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
por: Weintraub, Eric S., et al.
Publicado: (2022)

Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation
por: Lim, Yongwhan, et al.
Publicado: (2021)

Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine
por: Wang, Mingwei, et al.
Publicado: (2022)

Myocarditis and pericarditis after vaccination for COVID‐19
por: Hudson, Blake, et al.
Publicado: (2021)

Myocarditis, pericarditis with COVID-19 vaccines in the Netherlands
Publicado: (2021)

Myocarditis or pericarditis following COVID-19 vaccination
Publicado: (2021)

Myocarditis and pericarditis after COVID-19 vaccination
Publicado: (2021)

Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination
por: Pepe, Salvatore, et al.
Publicado: (2021)

Myocarditis, pericarditis included in labelling for two COVID vaccines
Publicado: (2021)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
por: Mahasing, Chayanit, et al.
Publicado: (2023)

Low rate of myocarditis/pericarditis after COVID-19 mRNA vaccines
Publicado: (2022)

COVID-19, Myocarditis and Pericarditis
por: Fairweather, DeLisa, et al.
Publicado: (2023)

Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
por: de Chaisemartin, Luc, et al.
Publicado: (2022)

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
por: Florea, Ana, et al.
Publicado: (2022)

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
por: Naveed, Zaeema, et al.
Publicado: (2022)

Incidence of Myocarditis after Messenger RNA Vaccine for COVID-19 in Young Male Recipients
por: Kato, Shingo, et al.
Publicado: (2022)

mRNA COVID-19 Vaccine Related Myocarditis and Pericarditis in the Australian Capital Territory
por: O'Driscoll, R., et al.
Publicado: (2022)

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
por: Calcaterra, Giuseppe, et al.
Publicado: (2021)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Myocarditis and Pericarditis in Patients with COVID-19
por: Shah, Jassim Zaheen, et al.
Publicado: (2020)

Tozinameran: Myocarditis and pericarditis: case report
Publicado: (2022)

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination( )
por: Chua, Gilbert T, et al.
Publicado: (2021)

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022)

Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age
por: Das, Bibhuti B., et al.
Publicado: (2021)

Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
por: Li, Minghui, et al.
Publicado: (2021)

Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series
por: Murakami, Yoshiki, et al.
Publicado: (2021)

Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers
por: Luk, Adriana, et al.
Publicado: (2021)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
por: Alami, Abdallah, et al.
Publicado: (2022)

COVID-19-Induced Myocarditis and mRNA Vaccine-Related Pericarditis: A Case Report
por: Voltarelli, Clara L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7bpj20na2cricbq90l37op4mc